PROBABILITY OF HOSPITALIZATION AND DEATH AMONG COVID-19 PATIENTS WITH COMORBIDITY DURING OUTBREAKS OCCURRING IN MEXICO CITY

INTRODUCTION

The original outbreak of SARS-CoV-2 occurred in the province of Wuhan, China, in November 2019.[1] It then spread rapidly worldwide and was categorized as a pandemic by the WHO in 2020.[2] During the progress of the pandemic in several regions of the world, it was observed that being elderly, having chronic obstructive pulmonary disease, diabetes mellitus (DM), arterial hypertension, or obesity were common features among individuals who required hospitalization or died and were associated with increased risk for the development of the disease [3] caused by the SARS-CoV-2 virus (COVID-19).

This association has been systematically observed throughout the world, the basis of which seems to be the pro-inflammatory state suffered by patients living with these chronic non-communicable diseases.[4] It has also been observed that patients with uncontrolled hypertension develop an excess of receptors ACE-2.[5] Since these conditions are common in adults around the world, obesity and being overweight particularly, as well as uncontrolled or undiagnosed DM or hypertension, COVID-19 has found fertile ground in which to take root and spread. The disease has a good chance of permanently residing in this environment and infecting other individuals with poor or limited immunity mechanisms, such as people with organ transplants, patients with neoplastic diseases undergoing chemotherapy, patients with chronic rheumatic diseases under immunosuppressive treatment, among other groups.[6]

The appearance of COVID-19 in the previously healthy population has attracted much attention recently since this disease has been observed in children, adolescents and young adults who are at risk of death or serious deterioration, in addition to the risks of kidney, lung, or liver complications, which can lead to permanent disability. It has also been observed that the risk of complications increases with the number of pre-existing comorbidities. Complications tend to be more frequent in men than in women, and in those patients who were admitted to intensive care units or required mechanical ventilation.[7] The pre-existence of overweight/obesity, DM, or hypertension (8) has meant that these complications have been observed frequently in the Mexican population. The prevalence of DM has been reported in adults over 20 years of age at rates of 10.3% throughout the country and 12.7% in Mexico City (CDMX); in the case of hypertension, 18.4% and 20.2%, respectively. While in the case of obesity, the figures are 75.2% (39.1% overweight and 36.1% obesity) and 75.9% (overweight 40.6% and obesity 35.3%), for the country as a whole and for Mexico City, respectively.[8]

The Mexico City Government has implemented various precautionary measures in the population based on the recommendations of the World Health Organization, the Federal Government, and the Metropolitan Committee on Health, [9-11] see Supplementary Tables 1, 2, and 3. In summary, these were:

1. Application of an epidemiological mobility/risk of transmission indicator, the Epidemiological ‘Traffic Light’, coded green, yellow, orange, and red for carrying out school, commercial, artistic, sports activities, etc. in CDMX. Code green indicates normal mobility with 0% risk of transmission and code red indicates the maximum application of containment measures corresponding to a >90% risk of transmission. The distribution of the different colours (risks) during the study period can be seen in Table S1.

2. Suspension of classes, activities in shopping centres, shows, restaurants and meeting places, places of entertainment or worship, and all kinds of face-to-face activities in the offices and dependencies of the CDMX government.

3. Promotion of the use of face masks while in public places and frequent handwashing with soap and water or at minimum with gel alcohol.

4. Provision of a medical guidance service for people presenting with symptoms of respiratory illness (fever, cough, sore throat, headache, tiredness), including the instruction to stay at home and send an SMS text message saying ‘COVID-19’ to the number 51515, support via the LOCATEL information service (55-5658-1111), on the CDMX website and via Facebook and via periodic monitoring.

5. Detection and follow-up of patient contacts.

6. Opening of several acute care hospitals for patients with COVID-19 and hiring of medical personnel.

7. Ambulance service to transfer patients from home to hospitals and referral between hospitals.

8. Opening Announcement of the first stage of the Temporary Unit to care for patients with COVID-19 at the Centro CitiBanamex supported by private donations.

9. Oxygen program in your home in collaboration with a private company (INFRA S.A. de C.V.), see Supplementary Tables S2 and S3.

In prior studies carried out by other Mexican groups [12,13] and in a study carried out by this group in the CDMX, [Sifuentes-Osornio J, Angulo-Guerrero O, Benítez-Pérez H, et al. Unpublished observations], a strong association between the severity of COVID-19, being over 40 years of age, and certain non-communicable chronic diseases, in particular DM, high blood pressure and obesity, was observed. This group has previously analysed the impact of comorbidities and different age ranges on the risk of developing complications. However, the evolution of the pandemic suggests the possibility that the changes could have occurred as a result of the interventions, as well as being due to changes in population dynamics, for example, mobility or the emergence of variants of concern in the country, among other conditions. [14,15] Therefore, the objective of this study was to compare the probability of death caused by COVID-19 in patients with comorbidities during three periods of the pandemic that we defined as first-wave (March 23 to July 12, 2020), interwave period (July 13 to October 25, 2020), and second-wave (October 26, 2020, to March 29, 2021), based on the different Case Fatality Rates (CFR) that we observed in the CDMX during the study period.

MATERIALS AND METHODS

RESULTS

Descriptive analysis

During the study period, a cohort of 2,260,156 subjects were included in the study, all having been tested for SARS-CoV-2 infection performed by nasopharyngeal RTq-PCR or antigen testing. The mean age of the subjects was 43.1 years (SD 15.0), 1,172,907 (51.9%) being women. The cohort included 194,647 individuals suffering from DM (8.6%); 262,652 had hypertension (11.6%), and 218,769 were obese (9.7%). Of the total of studied subjects, 666,694 tested positive (29.5%) to SARS CoV-2, having a mean age of 45.0 (SD 15.6). Of those testing positive, 340,811 (51.1%) were women. There was a considerable increase in the number of cases (+472%) of infection in all age groups between the first wave and the second. See Table 1. The number of subjects in each age bracket was as follows: 20 to 39 years of age: 273,715 (41% of whom tested positive), 140,248 being women (51.1%); 40 to 59 years of age: 269,285 (40.4% of whom tested positive), 139,241 being women (51.7%); 60 to 79 years of age: 109,467 (16.4% of whom tested positive) 53,964 being women (49.3%); 80 years of age and over: 14,227 (2.1% of whom tested positive), 7,358 being women (51.7%).

View this table:

• View inline
• View popup

Table 1: Sample size of the population tested and infected by SARS-CoV-2 by age groups and COVID-19 waves.

Of the total of infected individuals, 85,587 (12.8%) were hospitalized after being diagnosed as having severe respiratory acute infection. This total breaks down as follows: 24,023 of 82,489 infected people (29.1%) during the first wave; 16,935 of 112,115 (15.1%) during the interwave period, and 44,629 of 472,090 (9.5%) during the second wave.

Of the hospitalized subjects, there was an increase of +85.9% between waves, of +36.2% in the case of the group aged 20 to 39 years, +58.6% for the group aged 40 to 59, +121.2% for the group aged 60 to 79 years, and +171.4% for the 80 years or older group, see Table 2. This shows that the relative increase in hospitalizations between the first wave and the second increased linearly as a function of age groups, as seen in Figure 1.

View this table:

• View inline
• View popup
• Download powerpoint

Table 2: Sample size of hospitalized patients and mortality by COVID-19 by age groups and pandemic waves.

• Download figure
• Open in new tab

Figure 1.

An increase in the number of hospitalizations was observed with age group brackets

Correlation of hospital occupancy with hospital mortality

Considering that lethality increases during periods of higher transmission and demand for hospitalization, we calculated the Pearson correlation between weekly CFR for hospitalized patients and hospital occupancy. Figure 2 shows the time series for CFR and hospital occupancy. We observed that lethality across all age groups decreased as hospital occupation decreased at the end of the first wave, but then increased again during the second wave. Table 10 shows the correlation between weekly hospital occupation and CFR per age group, the correlation values were high in all age groups but the highest was seen in the 60 to 79 age group.

View this table:

• View inline
• View popup
• Download powerpoint

Table 10: Correlation between weekly hospital occupation and case fatality rate per age group.

• Download figure
• Open in new tab

Figure 2.

Pearson correlation between weekly case fatality rate (CFR) for hospitalized patients and hospital occupancy. Lethality increases during periods of higher transmission and demand for hospitalization. It was observed that lethality across all age groups decreased as hospital occupation improved at the end of the first wave and increased again during the second wave.

DISCUSSION

The data for this study come from a population of more than two million people analysed and reveal that even though a considerable increase was observed in the number of cases of infection (+472%), in the number of hospitalized subjects (+85.9%), and the number of hospitalized subjects and deaths (+102.4%) in all age groups between both waves, the probability of death diminished in the general population during the period studied, which is most probably due to the greater number of subjects studied after the first wave. Nevertheless, when analysing only those hospitalized individuals, with or without comorbidities, the CFR was high (50.2%). The probability of death increased considerably in all age groups, and this increase was more noticeable in individuals with previously identified comorbidities (DM, hypertension, or obesity). After concluding this analysis, we were struck by the increased probability of death in the groups of individuals without comorbidities, particularly in the groups aged 20 to 39 years and 40 to 59 years during wave episodes. This indicated to us that the youngest individuals had a very significant risk of death due to the severity of the disease which had led to their hospitalization. This result forces us to maintain the protective measures to avoid infection by the SARS-Cov-2 virus in the entire population, to intensify the vaccination program in young adults and adolescents and improve the medical care of those individuals requiring hospitalization, but with emphasis on the groups that we have identified as having significant risk.

The German team, Staerk et al. [21] described how effective IFRs (infection fatality rates) were estimated to vary over time as the age distributions of confirmed cases and estimated infections were changing during the pandemic. Alimohamadi et al. reported an interesting global analysis [22] of the CFR of COVID-19: the overall pooled CFR of COVID-19 was 10.0% (95% CI: 8.0-11.0). The pooled CFR of COVID-19 among the general population was 1.0% (95% CI: 1.0-3.0); while in hospitalized patients it was 13.0% (95% CI: 9.0-17.0). The pooled CFR in patients admitted into intensive care units was 37.0% (95% CI: 24.0-51.0), and in patients aged over 50, it was 19.0% (95% CI: 13.0-24.0). In our study, we observed a very high CFR in hospitalized COVID-19 patients (50.2%) because of the severity of the infection and its complications, although the high CFR can also be explained by the harmful effect of the saturation of hospital services occurring during the two waves (as can be seen in Figure 2) affecting people under 80 years of age, especially those between 20 and 59 years of age (as shown in Table 9). Our group has previously reported that 45% of patients who did not survive in a tertiary care hospital were not able to be admitted to the ICU due to the lack of availability of ICU beds.[23] Therefore, the mortality rate over time was mainly due to the availability of ICU beds, indirectly suggesting that overcrowding was one of the main contributing factors to hospital mortality. Above all, in this study, the risk observed in people of these age groups (under 60 years) without associated comorbidities is striking.

The risk of SARS-COV-2 infection associated with being over 60 was reported early in the course of the pandemic [24]. Additionally, in both China and the USA, DM, arterial hypertension, and obesity were reported as comorbidities that increase the risk of severe disease, hospitalization, and death.[25] Also early on, a respiratory-onset viral infection was identified as generating progressive multi-organ disease leading initially to respiratory failure and later to multi-organ failure.[26] All of the above are related to an inflammatory phenomenon called a cytokine storm [27], which causes extensive tissue damage with acute functional deterioration and specific organic sequelae in certain groups of patients.[28]

Early on, in Mexico and Latin America, several groups highlighted the rapid progression of patients with COVID-19 [12, 29-32] in coexistence with comorbidities such as DM, high blood pressure, and obesity, as being a worrying situation due to the high prevalence of overweight/obesity, metabolic syndrome and DM in the Mexican population as per information collected by the latest ENSANUT.[8] Then again, we have observed that a good proportion of COVID-19 patients are people in their fourth and fifth decades of life, younger than the patients in the USA reports. Notably, we observed an 85.9% increase in the number of hospitalizations between the two outbreaks, indicative of the severity of the pandemic in the CDMX and evidence of the intense transmission that occurred in that period, there being a notable predominance of a variant designated B.1.1.519. We observed an overlap of the second wave (October 2020 to March 2021) with the emergence of variant B.1.1.519, which represented 74.3% of the sequences generated in CDMX (2296/3092) from November 2020 to May 2021, distributed evenly across CDMX.[15]

We observed that across all age groups, there was an increase in hospitalizations during the second wave, compared with the first wave. The relative growth in the number of hospitalizations as a function of age ranged from a +36.2% increase (from 3261 to 4442) in the 20-39 age group up to a +171.37% increase (from 1544 to 4190) in the 80+ group, as shown in Figure 1. This is evidence that all age groups contributed to the greater pressure on hospital occupation during the second wave, with the most notably increasing demand being in the older-aged groups. Similarly, we observed an increase in the number of deaths and an increase in the probability of death in all age groups with or without comorbidities as described in Table 4. We observed that the probability of dying among individuals with DM, obesity, or arterial hypertension and COVID-19 in the general population was initially reduced in all age groups because of the +800% increase in the number of subjects tested during the study when comparing first and second waves. However, the probability of death in individuals with DM, hypertension, or obesity who were hospitalized increased during the second wave in all age groups, confirming the associated risk observed among the population.

As a result of this careful analysis, we have been able to identify the increased risk of complications and death, between the first and second waves, in all groups of hospitalized patients without comorbidities, from 3.74% in the group aged 20 to 40 to 9.34% in the group of patients aged 40 to 60, which reveals the risk to this population, primarily considered to be healthy. In the healthy population, the appearance of the multisystem inflammatory syndrome has been widely described, especially in children,[33] although at the beginning of the pandemic, it was confused with Kawasaki syndrome. A similar pattern has been described in adults from various regions of the world, in whom a picture of shock rather than respiratory failure [33,34] has been observed, associated with a high risk of death. In such patients, the PCR tests may be negative because it can manifest during the acute phase of the disease or as a postinfectious condition. This clinical scenario has been observed in Mexican children and reported by the group of the National Institute of Paediatrics. [35] In this report, 62% of the studied population did not report previous diseases and it is conceivable that a fraction of this population had presented with this multisystem inflammatory syndrome, however, we recognize that we cannot affirm that this would have been the diagnosis. Therefore, more research is required to ascertain if this condition exists in the Mexican population.

Attention has recently been drawn to the appearance of severe COVID-19 in groups of people without comorbidities. In fact, the study recently published by ISARIC WHO Clinical Characterization Protocol (UK) draws attention to the appearance of serious disease in this group of people and their need for hospitalization. In consequence, they have pointed out that it is helpful to look for other outcomes such as disability or chronic damage that may appear in the members of this group who survive but may develop complications in the medium and long term.[7] Recently, loci and genes associated with susceptibility to COVID-19 or to severe COVID-19 have been identified through the use of comprehensive GWAS (Genome-wide association studies) or analysis of genome, exome, or candidate genes.[36,37] Some of the loci reported include ABO blood groups, [36] ACE2 receptor,[38] TMPRSS2 (host transmembrane serine protease), [38] various HLA, [39] APOE,[40] and IFITM3 (interferon-induced transmembrane protein-3) [41] alleles. On the other hand, rare variants in genes encoding members of the type I/III interferon (IFN) pathway showed a higher estimated risk of severe COVID-19,[42] and some rare and deleterious germline variants in the X chromosome Toll-like receptor 7 (TLR7) gene have also been reported in young, healthy men with severe COVID-19,[43], these being possible immune defects that may explain the COVID-19 severity among these otherwise healthy people.

Based on our results, the results of the study carried out by our group in the tertiary care hospital [23] and the results of other recently published studies,[30] we consider that it is necessary to carry out the following measures to avoid an increase in the rates of lethality in hospitalized patients. The first measure is, without a doubt, to intensify public health measures shown to decrease transmission (use of face masks, social distancing, and continuous application of hygiene measures). The second is the intensification of vaccination among different age groups progressively until the entire population is covered. In this way, we can significantly reduce the number of cases of hospitalization, episodes of aggravation of disease, transfers to intensive care units, and the need for endotracheal intubation, as well as avoid cases of disability and death. (The data for Mexico City are currently under analysis). The third measure is the promotion of early care to recognize patients with risk comorbidities or those individuals with clinical manifestations or alterations in laboratory tests, indicative of severity or progressive deterioration.[44]

As regards the limitations and strengths of this study, its main limitation was that the recruitment method of the persons infected by SARS-CoV-2 was modified from symptomatic during the first wave to both asymptomatic and symptomatic in the other two periods, in addition to the modification of the diagnostic procedure from tPCR to antigen detection for the screening method. This condition prevented an adequate calculation of the infection fatality rate since the inclusion of symptomatic individuals predominated in the screening system. Another significant limitation was being unable to follow up on all the contacts of at least hospitalized patients to gain a better understanding of the severity of transmission. Furthermore, there were problems registering deaths and difficulties completing the registration, especially during the first wave. Therefore, for patients who died without a PCR-SARS-CoV-2 test, a ‘probable COVID-19’ code was added to include those patients without a confirmatory test. On the other hand, although this was not designed as a population-based study, the study’s main strength remains in its inclusion and consideration of all hospitalized patients, exploring their outcomes and carrying out the entire probabilistic and Bayesian analysis. Although the SISVER database might include some ‘measurement uncertainty’, the Bayesian model is not affected by this kind of ‘uncertainty’ since the potential biases were incorporated into the priors from the start. Thus, the resulting analysis model was in some sense ‘strengthened’ by this strategy.

CONCLUSION

This observational study revealed a considerable increase in the number of cases (+472%) of infection plus an +85.9% increase in hospitalized cases in all age groups between the first and second waves. Additionally, 12.8% of the infected persons were hospitalized because of severe COVID-19, with a high mortality rate among the hospitalized patients (>50%). Case Fatality Rates among hospitalized patients were higher during the peaks than during the interwave period. A higher probability of death was observed among hospitalized patients who suffered from diabetes, obesity, or hypertension. This probability increased during periods of higher hospital demand. It should be noted that this increase in the risk of death was observed in all age groups, regardless of the presence or absence of comorbidities.

SUPPLEMENTARY MATERIAL